WallStreetZenWallStreetZen

NASDAQ: BBIO
Bridgebio Pharma Inc Stock Ownership - Who owns Bridgebio Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bridgebio Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Hannah ValantineDirector2025-06-104,292$40.00
$171.68kSell
Hannah ValantineDirector2025-06-104,292$16.75
$71.89kBuy
Neil KumarChief Executive Officer2025-05-2075,000$33.40
$2.51MSell
Neil KumarChief Executive Officer2025-05-19400$33.75
$13.50kSell
Neil KumarChief Executive Officer2025-05-1925,756$33.32
$858.27kSell
Thomas TrimarchiPresident and CFO2025-05-1621,317$33.84
$721.37kSell
Maricel ApuliChief Accounting Officer2025-05-164,780$33.84
$161.76kSell
Neil KumarChief Executive Officer2025-05-1632,854$33.84
$1.11MSell
Kkr Genetic Disorder LP10% Owner2025-05-126,000,000$34.20
$205.20MSell
Andrew LoDirector2025-05-02100,000$38.50
$3.85MSell

1 of 6

BBIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BBIO insiders and whales buy or sell their stock.

BBIO Shareholders

What type of owners hold Bridgebio Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kkr Group Partnership LP19.43%36,900,661$1.47BInsider
Viking Global Performance LLC14.02%26,620,991$1.06BInsider
Viking Global Investors LP11.62%22,055,375$877.36MInsider
Viking Global Investors LP11.62%22,055,375$877.36MInstitution
Kohlberg Kravis Roberts Co LP10.14%19,260,971$766.20MInstitution
Vanguard Group Inc7.85%14,900,145$592.73MInstitution
Blackrock Inc7.03%13,357,496$531.36MInstitution
Kkr Genetic Disorder LP6.98%13,260,971$527.52MInsider
Neil Kumar4.21%8,002,909$318.36MInsider
Janus Henderson Group PLC3.78%7,171,399$285.28MInstitution

1 of 3

BBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BBIO62.44%37.56%Net SellingNet Selling
RVMD90.59%9.41%Net BuyingNet Selling
CORT29.74%70.26%Net BuyingNet Selling
ROIV40.80%59.20%Net SellingNet Selling
VRNA10.60%52.42%Net SellingNet Selling
View Top Biotech Stocks

Bridgebio Pharma Stock Ownership FAQ

Who owns Bridgebio Pharma?

Bridgebio Pharma (NASDAQ: BBIO) is owned by 97.52% institutional shareholders, 58.67% Bridgebio Pharma insiders, and 0.00% retail investors. Kkr Group Partnership LP is the largest individual Bridgebio Pharma shareholder, owning 36.90M shares representing 19.43% of the company. Kkr Group Partnership LP's Bridgebio Pharma shares are currently valued at $1.47B.

If you're new to stock investing, here's how to buy Bridgebio Pharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.